That last question sounds cold, but for patients and families it is painfully practical. How risky is this tumor? How much does surgery help? Which clues matter now, and which matter later? A new study in Radiology: Artificial Intelligence tries to answer that with a multimodal deep learning model...
Inside a cancer cell, the manufacturing floor is supposed to have a built-in shutdown switch for defective products. BCL-2 is the smug middle manager who keeps slapping "keep running" stickers on cells that absolutely should have been escorted out by security. Sonrotoclax shows up like the auditor...
A 52-year-old woman has already done the exhausting part - surgery, chemo, the whole life-rearranging mess - and then her oncologist has to say the sentence nobody wants to hear: the tumor is responding less to paclitaxel. Same drug. Same goal. Different tumor attitude. That is the problem sitting...
Most people think targeted cancer drugs fail because the tumor finds one dramatic new mutation, but sometimes the real problem is pettier than that: you block one escape route, and the cell quietly opens a side door.
Your peritoneum is a thin, slippery membrane that helps your abdominal organs move around without turning every lunch into a friction experiment. Unfortunately, colorectal cancer can treat that surface like a bonus expansion pack. Once tumor cells spread there, the disease gets harder to control,...
Pancreatic cancer is one of those diseases that has spent decades humiliating tidy ideas. It hides deep in the body, builds a dense, unfriendly neighborhood around itself, and often becomes hypoxic, meaning low in oxygen. That is bad news for photodynamic therapy, or PDT, because PDT usually needs...
Today’s forecast inside the tumor microenvironment: low oxygen, scattered immune dysfunction, and a high chance of trouble drifting into nearby lymph nodes by evening. In other words, the neighborhood around a breast tumor is less “healthy tissue” and more “storm front with bad management,” which...
Choose your own adventure: Door A says start mammograms at 40 and keep the scanner on a steady rhythm. Door B says 50 is the sweet spot for most average-risk women. Door C opens into a conference room where doctors, statisticians, and people with dense breasts are all arguing at once, which is...
Cells are built like old city blocks: load-bearing walls, backup wiring, repair crews, and at least one suspicious side entrance nobody noticed until the inspector showed up with a flashlight. In this story, that side entrance belongs to USP1, a protein cancer cells seem very happy to keep propped...
A new study from Korea looked at exactly that weirdness in the Korean national lung cancer screening program, which uses low-dose CT scans in high-risk people. The researchers analyzed 235,753 participants who had a baseline scan between 2019 and 2021 and stayed lung cancer-free for the next 2...
The cancer here is extranodal NK/T-cell lymphoma, or ENKTL. It is rare, often linked to Epstein-Barr virus, and it tends to grow outside lymph nodes, usually in the upper aerodigestive tract - think nose, sinuses, and nearby real estate nobody wants a tumor renting. It can also show up in more...
Radiation beams, manganese ions, and a whiff of carbon monoxide are not the usual trio you expect to team up against cancer, but here we are.
The Bermuda Triangle has spent decades making people argue about missing ships, missing planes, and whether humans can ever resist a dramatic overinterpretation. Chronic lymphocytic leukemia, or CLL, has its own version of that problem: a suspicious stretch of DNA on chromosome 14 called the...
Obituary: old-school glioblastoma immune profiling, age "surprisingly recent," passed away after a long struggle with invasive tissue sampling, partial snapshots, and the general inconvenience of needing actual tumor pieces every time biology changed its mind.
The problem with triple-negative breast cancer is that it plays defense, offense, and special teams at the same time. It tends to recur, spread, and shrug at standard treatments like a cellular menace wearing noise-canceling headphones. That is why this new paper on lanthanum cuprate nanosheets...
That, more or less, is the problem in head and neck squamous cell carcinoma, or HNSCC: the cancer is not one thing, and its immune neighborhood is not one thing either. Which means treating every case like it came off the same factory line was always a bit optimistic in the way protocol amendments...
Cancer research sometimes feels like gardening with a flamethrower - first you spot the weeds, then you pray your tool can scorch the bad patch without turning the rest of the yard into soup. That is basically the promise behind a new paper on a squaraine dye called SQ8: build a molecule that helps...
This paper opens like a caper movie: calorie restriction slips into the vault, cuts the alarm wires, and seems ready to block breast cancer from making its getaway to the lungs. Then voluntary exercise shows up like the charming accomplice who accidentally leans on the laser grid. Not villain...
Pediatric high-grade glioma, or pHGG, is one of those diagnoses that makes medicine sound far more in control than it really is. It is an aggressive childhood brain cancer, and despite surgery, radiation, and chemo, it often comes back. Badly. What this new paper does is stop treating pHGG like a...
Cervical cancer behaves like a smug little plotter in a heist movie. It does not kick the front door down. It lingers in the hallway, learns the security schedule, and waits for the exact moment the alarm system gets weird enough to make a run for it.